Business

Watch Reside: The principle FDA panel discusses whether or not to advocate Moderna's Covid vaccine for emergency use

watch-reside-the-principle-fda-panel-discusses-whether-or-not-to-advocate-modernas-covid-vaccine-for-emergency-use

[The stream is scheduled to start at 9 a.m. Please refresh the page if you don't see a player above at this time.]

A panel of the Food and Drug Administration meets Thursday to vote on whether to recommend approval of Moderna's coronavirus vaccine for emergency use.

Before the vote, which is expected to take place at the end of the day, the Agency's Advisory Committee on Vaccines and Related Biological Products will review and discuss Moderna clinical trial data and provide its opinion on the vaccine, including whether the benefits are the risks for a vaccine, emergency approval predominates.

The FDA is not required to follow the advice of the advisory group, but it often does.

A positive vote from the committee will likely pave the way for the FDA to approve Moderna's emergency vaccine. It would be the second to be approved for use in the US after Pfizer's vaccine.

The all-day meeting takes place from 9 a.m. to 5:15 p.m.

Read CNBC's live updates for the latest news on the Covid-19 outbreak.

0 Comments
Share

Steven Gregory